INDIES PHARMA JAMAICA LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.79 JMD | +5.28% |
|
+6.90% | -9.71% |
| Sales 2022 | 937M 6.05M 479M | Sales 2023 | 1.06B 6.81M 539M | Capitalization | 4.18B 27.01M 2.14B |
|---|---|---|---|---|---|
| Net income 2022 | 221M 1.43M 113M | Net income 2023 | 213M 1.38M 109M | EV / Sales 2022 | 5.08 x |
| Net Debt 2022 | 581M 3.75M 297M | Net Debt 2023 | 645M 4.17M 330M | EV / Sales 2023 | 4.58 x |
| P/E ratio 2022 |
19
x | P/E ratio 2023 |
19.6
x | Employees | 71 |
| Yield 2022 |
3.6% | Yield 2023 |
3.61% | Free-Float | 99% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +5.28% | ||
| 1 week | +6.90% | ||
| Current month | +1.82% | ||
| 1 month | +3.33% | ||
| 6 months | -5.42% | ||
| Current year | -9.71% |
1 week
2.50
2.79
1 month
2.402.79
Current year
2.253.04
1 year
2.253.53
3 years
2.253.96
5 years
1.254.90
10 years
1.254.90
| Managers | Title | Age | Since |
|---|---|---|---|
Vishnu Muppuri
FOU | Founder | - | 08/12/03 |
Guna S. Muppuri
FOU | Founder | - | 08/12/03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Aubyn Hill
BRD | Director/Board Member | - | - |
Guna S. Muppuri
FOU | Founder | - | 08/12/03 |
Vishnu Muppuri
FOU | Founder | - | 08/12/03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/06/24 | 2.79 | +5.28% | 426,862 |
| 27/06/24 | 2.65 | 0.00% | 127,720 |
| 26/06/24 | 2.65 | 0.00% | 98,555 |
| 25/06/24 | 2.65 | +0.38% | 133,917 |
| 24/06/24 | 2.64 | +1.15% | 3,124 |
End-of-day quote JAMAICA STOCK EXCHANGE, June 27, 2024
More quotes
Indies Pharma Jamaica Limited is a Jamaica-based pharmaceutical company. The Company is engaged in the distribution and retailing of pharmaceutical and auxiliary products. It distributes over 150 prescription and non-prescription or over the counter generic pharmaceutical products for Bioprist Holdings Limited under the Bioprist Pharmaceuticals brand in addition to other products being sold under the orthopedic and joint rehabilitation segment. The Company services customers across all 14 parishes of the island, including over 400 pharmacies, private and public hospitals, and government agencies, including the National Health Fund as well as medical practitioners and directly to individual end users. Its products include Indapamide SR 1.5 milligram (mg), Amlodipine 5mg, Amlodipine 10mg, Amlodipine 5mg + Valsartan 80mg, Amlodipine 5mg + Valsartan 160mg, Amlodipine 10mg + Valsartan 160mg, Valsartan 80mg, Valsartan 160mg, Domperidone 10mg, Tamoxifen 10mg, Enalapril 5mg, and others.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -9.71% | 22.63M | |
| -2.46% | 23.95B | |
| +14.23% | 8.7B | |
| +1.47% | 8.29B | |
| -32.92% | 6.7B | |
| +18.62% | 5.38B | |
| +1.10% | 4.08B | |
| -9.24% | 3.79B | |
| -10.20% | 3.3B | |
| +7.11% | 3.19B |
- Stock Market
- Equities
- INDIES Stock
